Partner

Charles B. Hughes

212.885.8859 chughes@bartonesq.com
Partner

Charles B. Hughes

212.885.8859 chughes@bartonesq.com
View All Attorneys

Charles is a leading practitioner in the areas of venture capital and private equity transactions and fund formations. He has extensive experience representing funds in the preparation for and completion of their fundraising processes as well as with respect to the funds’ investments. He has handled several hundred Series A, B, C, D, and convertible debt financings for venture funds and emerging growth companies. He regularly handles the purchase and sale of portfolio companies.

Charles’ expertise includes advising institutional investors and family offices regarding equity investments and purchases of senior and mezzanine debt. His experience includes extensive work on cross-border transactions.

Charles serves on numerous Boards of Directors and regularly advises Boards on corporate governance matters and with respect to their fiduciary obligations. He has vast experience in advising the Boards and negotiating the full spectrum of corporate infrastructure documentation, including charters and by-laws, stockholder agreements, investor rights agreements, voting agreements, employment agreements and incentive compensation plans.

Prior to joining Barton, Charles served for ten years as a Partner and General Counsel of Easton Capital where he has held a seat on the investment committee of each of Easton’s five primary venture funds. He continues to serve on those investment committees as well as on the Boards of several Easton portfolio companies in the areas of healthcare, information technology and digital media.

Charles currently serves on the Boards of several non-profit organizations and foundations. He has spoken at numerous venture capital and private equity conferences including the annual ILPA conference and the New York Capital Roundtable.

Prior to joining Easton, Charles spent twelve years as a partner at Torys LLP and its predecessor firm where he was a nationally recognized corporate and transactional partner concentrating on venture capital and private equity investments, mergers and acquisitions and fund formations.

Charles B. Hughes - SuperLawyers

 

Practices
Industry Experience
B

Matters

Close
Business Transactions, Emerging Companies, & Venture Capital
  • Managed Convertible Promissory Notes Offering
    • Represented CoreMedica Laboratories Inc. with respect to the offering of its Convertible Promissory Notes.
  • Managed Secondary Sale of Series A Interests
    • Represented Azimuth Quartzy Fund LLC in connection with the secondary sale of Series A Interests in the Fund.
  • Managed Secondary Sale of Unites by JP Morgan to Goldman Sachs
    • Represented a major venture capital fund in the successful secondary sale of units by JP Morgan to Goldman Sachs Management entity.
  • Oversaw $3 Million Offering of Series A-1 Preferred Stocks
    • Represented CoreMedica Laboratories Inc. in connection with its $3 MM offering of Series A-1 Preferred Stocks.
  • Oversaw $8 Million Offering of Series C Preferred Units
    • Represented Scientific Intake Co. LLC in the offering of $8 MM of its Series C Preferred Units.
  • Advised on Emerging Growth Company’s Convertible Promissory Notes
    • Represented an emerging growth imaging company in the $1.3 MM offering of its Convertible Promissory Notes.
  • Represented Investors in $5 Million Purchase of Series A Preferred Units
    • Represented the investment group in the purchase of $5MM of Series A Preferred Units of a fast casual restaurant company.
  • Aided Venture Capital Fund in Purchase of Convertible Promissory Notes
    • Represented a major venture capital fund in connection with the purchase of Convertible Promissory Notes in an emerging growth medical diagnostics company.
  • Formed Series of Special Purpose Vehicles
    • Represented Arrowhead Capital LLC regarding the formation of a Series of Special Purpose Vehicles in the Cayman Islands for offshore investments.
  • Represented Venture Capital Fund in Secondary Sale of Series A Interests
    • Represented Easton Capital Partners, LP in the secondary sale of certain Series A Interests in the Fund.
  • Aided Medical Lab in Strategic Acquisition
    • Represented CoreMedica Laboratories Inc. in its acquisition of two Swiss biotech companies. 
  • Represented Maritime Industry Software Company in Series A Preferred Stock Offering
    • Represented Burmester & Vogel Ltd. (a company specializing in developing and licensing software for the maritime industry) in its corporate formation, offering, and sale of Series A Preferred Stock and acquisition of a German marine technology company.
  • Counsel to AI Healthcare Platform During Its Formation and Funding
    • Represented Cognome, Inc. (an AI healthcare platform) in its formation and spin out from a major hospital system, including licensing of technology and preparation for preferred stock offering.